Atlas Trials

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

Clinical trial NCT05759923 · RECRUITING

Trial details

NCT number
NCT05759923
Sponsor
Molecure S.A.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Ovarian CarcinomaAdvanced Renal Cell CarcinomaAdvanced Pancreatic CarcinomaAdvanced Colorectal CarcinomaMetastatic Pancreatic CarcinomaMetastatic Colorectal CarcinomaMetastatic Renal Cell CarcinomaMetastatic Ovarian Carcinoma
Start date
2023-01-26
Primary completion
2027-03-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.